$2.52
-0.0100-0.40%
Pre-Market: 4:09 PM EDT
15 minutes delayed
Oramed Pharmaceuticals
ORMPNASDAQ
Oramed Pharmaceuticals (ORMP) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestOverview Rating
Speculative
Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Quotes, Forecast and News Summary
Oramed Pharmaceuticals Stock (NASDAQ: ORMP) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 131.89K |
| Day Range | - - - |
| 52 Wk Range | 1.67 - 3.67 |
| Market Cap | $102.38M |
| P/E Ratio | 9.77 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 57 |
| Short Interest | 1.43% |
| Days to Cover | 2.04 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Oramed Pharmaceuticals, Inc
Sector
Health Care
Industry
Pharmaceuticals
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and developme...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Oramed Pharmaceuticals (ORMP) stock?
You can purchase shares of Oramed Pharmaceuticals (NASDAQ:ORMP) through any online brokerage.
Who are Oramed Pharmaceuticals (ORMP) competitors?
Other companies in Oramed Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI), Marinus Pharma (NASDAQ:MRNS), Nutriband (NASDAQ:NTRB) and Telomir Pharmaceuticals (NASDAQ:TELO).
What is the target price for Oramed Pharmaceuticals (ORMP) stock?
There is no analysis for Oramed Pharmaceuticals.
What is the forecast for Oramed Pharmaceuticals (ORMP) stock?
Oramed Pharmaceuticals has a consensus price target of $20.50.
Current stock price for Oramed Pharmaceuticals (ORMP)?
The stock price for Oramed Pharmaceuticals (NASDAQ: ORMP) is $2.52 last updated July 15, 2024 at 4:09 PM EDT.
Does Oramed Pharmaceuticals (ORMP) pay a dividend?
There are no upcoming dividends for Oramed Pharmaceuticals.
When is Oramed Pharmaceuticals (NASDAQ:ORMP) reporting earnings?
Oramed Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Oramed Pharmaceuticals (ORMP) going to split?
There is no upcoming split for Oramed Pharmaceuticals.
What sector and industry does Oramed Pharmaceuticals (ORMP) operate in?
Oramed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.